In a move fraught with international political overtones, Italy’s new Minister of Health is moving to replace the Director General of the Italian Drug Agency (AIFA), Dr Luca Li Bassi, who was the key architect of the May World Health Assembly (WHA) resolution supporting greater price transparency in medicines markets, Health Policy Watch has learned. […] Continue reading ->
Some 11,258 scientists from 153 countries have issued a sharp warning in the journal BioScience, about the climate emergency faced by the global community. The scientists calls for “bold and drastic transformations” in six key areas to pull earth from the precipice of potentially catastrophic deterioration in basic life support systems. Their prescription includes: a […] Continue reading ->
Demonstrators poured onto the streets and politicians pointed fingers as Delhi’s air pollution levels soared above the threshold air quality monitoring stations could record on Sunday. The Indian Supreme Court issued a scathing statement calling for politicians to stop “passing the buck” on the air pollution issue and take urgent action in the “public health […] Continue reading ->
Cutting-edge health technologies – such as gene editing therapies for cancer – have the potential to save lives, and the international intellectual property system should be leveraged to drive innovation and bring those therapies to people who need them, said the leaders of global health, trade and intellectual property agencies at a Trilateral Symposium on […] Continue reading ->
Non-communicable diseases (NCDs) such as cancer, heart disease and stroke, as well as road traffic injuries, are among the leading causes of death in cities – killing some 42 million people worldwide every year. A new report released by the World Health Organization shows how urban leaders can tackle these urban maladies through simple environmental […] Continue reading ->
Berlin, Germany – A “public interest R&D” model can bring effective treatments for neglected diseases to patients at comparatively low cost, through a collaborative, access-oriented development process. The model is outlined in the new report 15 Years of Needs-Driven Innovation for Access, by Drugs for Neglected Disease Initiative (DNDi), released Wednesday. The model etches an […] Continue reading ->